Merck Sharp & Dohme LLC recalled 51,320 cartons of Belsomra (suvorexant) tablets after identifying a risk of delayed dissolution. This defect can delay the release of the drug, hindering sleep onset. Consumers and healthcare providers should stop using the product immediately and contact the company for guidance.
Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
Consumers and healthcare providers should stop using this product immediately. Contact Merck & Co. Inc or your healthcare provider for guidance. Notification method: N/A
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Belsomra (suvorexant) is a prescription drug used to treat insomnia by helping patients fall asleep faster and stay asleep longer. Consumers buy it primarily for its efficacy in managing sleep disorders.
The recall is due to failed dissolution specifications that may cause the drug to not release into the bloodstream effectively, delaying its intended sleep-inducing effects.
This recall is not part of a broader industry pattern.
Consumers may face disruptions in their sleep patterns and could experience increased anxiety or frustration related to sleeplessness due to the potential ineffectiveness of the recalled tablets.
The lot number and expiration date can usually be found on the bottom or back of the carton or blister pack.
Expect a refund processing time of 4-6 weeks after returning the recalled product.
Keep records of your purchase, receipts, and any communication with Merck or your healthcare provider involving the recall.
Brand: Belsomra Model Numbers: Lots 2090019 and 2123744 Quantity: 51,320 cartons Where Sold: Nationwide in the USA and Puerto Rico NDC: 0006-0033-10 (Shellpack), 0006-0033-30 (Carton Label)
No injuries or incidents have been reported.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.
ZOLIQUEX recalled adult portable bed rails sold on Amazon after reports of entrapment and asphyxiation risk. The recall targets silver bed rails measuring 12.4 inches wide by 33.07 inches tall and weighing 7.1 pounds. The model numbers ZEX014-V1 and the Zoliquex branding appear on packaging. Stop using the product and seek a full refund by contacting ZOLIQUEX.
Vitaquest International recalled Arey Not Today iron supplements sold at retailers nationwide after determining the products do not meet the Poison Prevention Packaging Act's child-resistant packaging requirement. The noncompliant packaging creates a poisoning risk to young children if ingested. Consumers should stop using the products immediately and contact Vitaquest for a free child-resistant替换
Easymake adult portable bed rails imported by ZFZG-US are recalled on April 9, 2026. The recall cites a risk of entrapment and asphyxiation and notes the product lacks required hazard warning labels. Stop using the recalled rails immediately and contact ZFZG-US for a full refund.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Sangohe expands its 2026 recall of adult portable bed rails 504E and 504Q due to entrapment and asphyxiation risk. The recall cites noncompliance with the mandatory standard and missing warning labels. Stop using the recalled rails and pursue a full refund by contacting Sangohe.
Tuymec Minoxidil Hair Growth Kit sold on Amazon by DrHealBeauty is recalled for non-child-resistant packaging. The kit contains two black spray bottles with 5% minoxidil and BIOTIN labels. Consumers should stop using the product immediately and contact DrHealBeauty for a free empty replacement bottle with a child-resistant closure.
TecFlox recalled its Minoxidil Topical Solution hair growth serum bottles on April 2, 2026. The packaging is not child-resistant, violating the Poison Prevention Packaging Act. Consumers should stop using the product immediately, store it out of reach of children, and email TecFloxrecall@outlook.com to receive free replacement bottles. Only bottles with serum remaining will be replaced; dispose of